Researchers report encouraging immunotherapy option for relapsed myeloma patients
Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies ...
Sep 1, 2022
0
39